SlideShare une entreprise Scribd logo
1  sur  11
Télécharger pour lire hors ligne
General Wellness:
Policy for Low Risk Devices
Draft Guidance for Industry and
Food and Drug Administration
Staff
DRAFT GUIDANCE
This guidance document is being distributed for comment purposes only.
Document issued on: January 20, 2015.
You should submit comments and suggestions regarding this draft document within 90 days of
publication in the Federal Register of the notice announcing the availability of the draft
guidance. Submit written comments to the Division of Dockets Management (HFA-305),
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit
electronic comments to http://www.regulations.gov. Identify all comments with the docket
number listed in the notice of availability that publishes in the Federal Register.
For questions regarding this document, contact the Office of the Center Director at 301-796-
5900.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Preface
Additional Copies
Additional copies are available from the Internet. You may also send an e-mail request to
dsmica@fda.hhs.gov to receive an electronic copy of the guidance or send a fax request to 301-
847-8149 to receive a hard copy. Please use the document number 1300013 to identify the
guidance you are requesting.
Table of Contents
I. INTRODUCTION .......................................................................................................................................1
II. POLICY ON LOW RISK GENERAL WELLNESS PRODUCTS .........................................................2
III. GENERAL WELLNESS PRODUCTS......................................................................................................3
IV. LOW RISK...................................................................................................................................................5
V. EXAMPLES OF LOW RISK GENERAL WELLNESS PRODUCTS ...................................................6
DECISION ALGORITHM FOR GENERAL WELLNESS PRODUCTS ......................................................8
Contains Nonbinding Recommendations
Draft - Not for Implementation
1
General Wellness:
Policy for Low Risk Devices
Draft Guidance for Industry and
Food and Drug Administration Staff
This draft guidance, when finalized, will represent the Food and Drug Administration's
(FDA's) current thinking on this topic. It does not create or confer any rights for or on
any person and does not operate to bind FDA or the public. You can use an alternative
approach if the approach satisfies the requirements of the applicable statutes and
regulations. If you want to discuss an alternative approach, contact the FDA staff
responsible for implementing this guidance. If you cannot identify the appropriate FDA
staff, call the appropriate number listed on the title page of this guidance.
I. Introduction
The Food and Drug Administration (FDA) is issuing this guidance document to provide
clarity to industry and FDA staff on the Center for Devices and Radiological Health’s
(CDRH’s) compliance policy for low risk products that promote a healthy lifestyle (general
wellness products)1
. This guidance does not apply to products (e.g., drugs, biologics, dietary
supplements, foods, or cosmetics) regulated by other FDA Centers or to combination
products,2
including those regulated by CDRH.
FDA's guidance documents, including this guidance, do not establish legally enforceable
responsibilities. Instead, guidances describe the Agency's current thinking on a topic and
should be viewed only as recommendations, unless specific regulatory or statutory
1 This guidance does not change or rescind any requirements of the FD&C Act or any applicable regulations.
This guidance also does not preclude FDA from consulting with the Consumer Product Safety Commission
(CPSC) as to whether a general wellness product is a consumer product under CPSC’s authority or a device.
FDA may coordinate with other agencies and authorities, such as the CPSC, to determine jurisdiction over
products. If a product is a device under section 201(h) of the FD&C Act, it is generally excluded from CPSC’s
authority over “consumer products” under the Consumer Product Safety Act (15 U.S.C. § 2052(a)(5)(ii)(H)).
However, CPSC and FDA may both have jurisdiction over certain medical devices under other statutory
authorities the CPSC administers.
2 For determinations on whether a combination product meets the statutory definition of a medical device,
contact the Office of Combination Products at combination@fda.gov.
Contains Nonbinding Recommendations
Draft - Not for Implementation
2
requirements are cited. The use of the word should in Agency guidance means that
something is suggested or recommended, but not required.
II. Policy on Low Risk General Wellness Products
CDRH does not intend to examine low risk general wellness products to determine whether
they are devices3
within the meaning of the FD&C Act or, if they are devices, whether they
comply with the premarket review and post-market regulatory requirements for devices under
the FD&C Act and implementing regulations, including, but not limited to: registration and
listing and premarket notification requirements (21 CFR Part 807); labeling requirements (21
CFR Part 801 and 21 CFR 809.10); good manufacturing practice requirements as set forth in
the Quality System regulation (21 CFR Part 820); and Medical Device Reporting (MDR)
requirements (21 CFR Part 803).
For purposes of this guidance, CDRH defines general wellness products as products that (1)
are intended for only general wellness use, as defined in this guidance, and (2) present a very
low risk to users’ safety. General wellness products may include exercise equipment, audio
recordings, video games, software programs4
and other products that are commonly, though
not exclusively, available from retail establishments (including online retailers and
distributors that offer software to be directly downloaded), provided these two criteria are
met.
CDRH regularly receives inquiries about whether particular products are devices as defined
by the FD&C Act. There are instances where certain general wellness products, as discussed
in this guidance, do not meet the definition of a device under section 201(h) of the FD&C Act
and therefore are not subject to the FD&C Act’s regulatory requirements for devices. We
have included examples of these kinds of products to illustrate the scope of this guidance,
rather than to suggest they meet the device definition.
A product's inclusion under this guidance does not establish that it has been shown to be safe,
effective, and not misbranded for its intended use.
3
The term “device” is defined in 201(h) of the FD&C Act to include an “instrument, apparatus, implement,
machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part,
or accessory, which is …intended for use in the diagnosis of disease or other conditions, or in the cure,
mitigation, treatment, or prevention of disease, in man … or intended to affect the structure or any function of
the body of man...”
4
For more discussion regarding FDA’s regulatory approach towards certain mobile medical applications, see the
FDA Guidance: Mobile Medical Applications, issued on September 25, 2013, available at
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM2633
66.pdf.
Contains Nonbinding Recommendations
Draft - Not for Implementation
3
III. General Wellness Products
A general wellness product, for the purposes of this guidance, has (1) an intended use that
relates to a maintaining or encouraging a general state of health or a healthy activity, or (2) an
intended use claim that associates the role of healthy lifestyle with helping to reduce the risk
or impact of certain chronic diseases or conditions and where it is well understood and
accepted that healthy lifestyle choices may play an important role in health outcomes for the
disease or condition).
If the product’s intended uses are not limited to the above general wellness intended uses, this
guidance does not apply.
The first category of general wellness intended uses involve claims about sustaining or
offering general improvement to conditions and functions associated with a general state of
health that do not make any reference to diseases or conditions. For the purposes of this
guidance, this first category of general wellness claims relate to:
· weight management,
· physical fitness, including products intended for recreational use,
· relaxation or stress management,
· mental acuity,
· self-esteem (e.g., devices with a cosmetic function that make claims related only to
self-esteem),
· sleep management, or
· sexual function.
The following are examples of this category of general wellness claims:
· Claims to promote or maintain a healthy weight, encourage healthy eating, or assist
with weight loss goals;
· Claims to promote relaxation or manage stress when there is no reference to anxiety
disorders or other reference to a disease or condition;
· Claims to increase, improve, or enhance the flow of qi;
· Claims to improve mental acuity, instruction following, concentration, problem-
solving, multitasking, resource management, decision-making, logic, pattern
recognition or eye-hand coordination;
· Claims to promote physical fitness, such as to help log, track, or trend exercise
activity, measure aerobic fitness, improve physical fitness, develop or improve
endurance, strength or coordination, or improve energy;
· Claims to promote sleep management, such as to track sleep trends;
· Claims to promote self-esteem, such as to boost self-esteem;
Contains Nonbinding Recommendations
Draft - Not for Implementation
4
· Claims that address a specific body structure or function, such as to increase or
improve muscle size or body tone, tone or firm the body or muscle, enhance cardiac
function, or enhance or improve sexual performance;
· Claims to improve general mobility or to assist individuals who are mobility impaired
or who have limited mobility in a recreational activity; and
· Claims to enhance an individual’s participation in recreational activities by
monitoring the consequences of participating in such activities, such as to monitor
heart rate or monitor frequency or impact of collisions.
The following are examples of claims that do not fall into this category of general wellness
claims:
· A claim that a product will treat or diagnose obesity;
· A claim that a product will treat an eating disorder, such as anorexia;
· A claim that a product helps treat anxiety;
· A claim that a computer game will diagnose or treat autism;
· A claim that a product will treat muscle atrophy or erectile dysfunction;
· A claim to restore a structure or function impaired due to a disease, e.g., a claim that a
prosthetic device enables amputees to play basketball.5
The second category of general wellness intended uses is comprised of two subcategories:
1) intended uses to promote, track, and/or encourage choice(s), which, as part of a
healthy lifestyle, may help to reduce the risk of certain chronic diseases or
conditions; and
2) intended uses to promote, track, and/or encourage choice(s) which, as part of a
healthy lifestyle, may help living well with certain chronic diseases or conditions.
Both subcategories of disease-related general wellness claims should only contain references
where it is well understood that healthy lifestyle choices may reduce the risk or impact of a
chronic disease or medical condition. That is, the claim that the healthy lifestyle choice(s)
may play an important role in health outcomes should be generally accepted; such
associations are typically described in peer-reviewed scientific publications. Examples of
chronic diseases for which a healthy lifestyle is associated with risk reduction or help in
living well with that disease include heart disease, high blood pressure, and type 2 diabetes.
The following are examples of this category of disease-related general wellness claims:
5
Devices intended to restore a structure or function impaired due to a disease may be regulated by FDA as
individually classified recreational use devices or products classified in a general classification. For example, an
artificial limb prosthesis intended to provide disabled persons the ability to run may be regulated under 21 CFR
890.3420 or 21 CFR 890.3500.
Contains Nonbinding Recommendations
Draft - Not for Implementation
5
· Product X promotes physical activity, which, as part of a healthy lifestyle, may help
reduce the risk of high blood pressure.
· Software Product Y tracks your caloric intake and helps you manage a healthy eating
plan to maintain a healthy weight and balanced diet. Healthy weight and balanced diet
may help living well with high blood pressure and type 2 diabetes.
· Product Z tracks activity sleep patterns and promotes healthy sleep habits, which, as
part of a healthy lifestyle, may help reduce the risk for developing type 2 diabetes.
IV. Low Risk
CDRH’s general wellness policy does not extend to devices that present inherent risks to a
user’s safety.
Whether a device is low risk for purposes of this guidance is determined by whether or not
the product:
1) is invasive6
;
2) involves an intervention or technology that may pose a risk to a user’s safety if device
controls are not applied, such as risks from lasers, radiation exposure, or implants;
3) raises novel questions of usability; or
4) raises questions of biocompatibility.
If the answer to any of these questions is yes, the device is not a low risk general wellness
product and is not covered by this guidance.
The following are examples of products that present inherent risks to a user’s safety and
would not be considered “low risk” as described in this guidance:
· Sunlamp products promoted for tanning purposes, due to risks to a user’s safety from
the ultraviolet radiation, including, without limitation, an increased risk of skin
cancer.
· Implants promoted for improved self-image or enhanced sexual function, due to risks
to users such as rupture or adverse reaction to implant materials, and risks associated
with the implantation procedure.
· A laser product that claims to improve confidence in user’s appearance by
rejuvenating the skin. Although the claims of rejuvenating the skin and improving
confidence in user’s appearance are general wellness claims, laser technology presents
risks of skin and eye burns and presents usability considerations that may be
addressed with labeling and other device controls.
6 For purposes of this guidance, “invasive” means penetrates or pierces the skin or mucous membranes of the
body.
Contains Nonbinding Recommendations
Draft - Not for Implementation
6
In assessing whether a device is low risk for purposes of this guidance, FDA recommends
that you also consider whether CDRH actively regulates products of the same type as the
product in question. For example, CDRH currently regulates external penile rigidity devices,
which are devices intended to create or maintain sufficient penile rigidity for sexual
intercourse, under 21 CFR 876.5020 as class II devices exempt from premarket notification
with special controls. The special controls for these devices address risks to health that are
associated with the use of these devices, including, without limitation, tissue injury, trauma
or infection.7
Therefore, these types of devices would not be considered low risk general
wellness products.
V. Examples of Low Risk General Wellness Products
Illustrative Example 1: A mobile application plays music to “soothe and relax” an individual
and to “manage stress.”
These claims relate only to relaxation or stress management, not to any disease or
medical condition, and thus are general wellness claims. In addition, the technology
to play music does not present inherent risks to a user’s safety. Therefore, this
product meets both criteria for a low risk general wellness product.
Illustrative Example 2: A mobile application that solely monitors and records daily energy
expenditure and cardiovascular workout activities to “allow awareness of one’s exercise
activities to improve or maintain good cardiovascular health.”
This claim relates to a specific organ only in the context of general health and does
not refer to a disease or medical condition. In addition, to the extent the monitoring
or recording exercise activities present risks (such as inaccuracy), when made in the
absence of disease or medical condition claims, the risks to the user’s safety are low.
Therefore, this product meets both criteria for a low risk general wellness product.
Illustrative Example 3: A mobile application monitors and records food consumption to
“manage dietary activity for weight management and alert the user, healthcare provider, or
family member of unhealthy dietary activity”.
This claim relates to dietary choices and weight management, and thus is a general
wellness claim. In addition, the technology for monitoring or recording food
consumption poses a low risk to the user’s safety. Therefore, this product meets both
criteria for a low risk general wellness product.
7 See the FDA Guidance: Class II Special Controls Guidance Document: External Penile Rigidity Devices,
issued on December 28, 2004, available at
http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm072098.htm.
Contains Nonbinding Recommendations
Draft - Not for Implementation
7
Illustrative Example 4: A portable product that claims to monitor the pulse rate of users
during exercise and hiking.
This claim relates only to exercise and hiking and does not refer to a disease or
medical condition. Thus, it is a general wellness claim. In addition, the technology
for monitoring poses a low risk to the user’s safety. Therefore, this product meets
both criteria for a low risk general wellness product.
Illustrative Example 5: A product is intended to mechanically exfoliate the face, hands and
feet to make the skin smoother and softer.
This claim relates to self-esteem and does not refer to a specific disease or medical
condition, and thus is a general wellness claim. In addition, the technology for
exfoliating the face poses a low risk to the user’s safety as it does not penetrate the
stratum corneum. Therefore, this product meets both criteria for a low risk general
wellness product.
Note: However, if the product exfoliates the skin to enhance the delivery of a
topically applied product containing one or more active pharmaceutical ingredients
through the stratum corneum, the product would present inherent risks to the user’s
safety because of its invasive nature. Therefore, then, the product would not be a low
risk general wellness product.
Contains Nonbinding Recommendations
Draft - Not for Implementation
8
Decision Algorithm for General Wellness Products
1. Does the product make only general wellness claims?
a. Does the product’s intended use and claims refer to sustaining or offering
general improvement to conditions and functions associated with a general
state of health: weight management, physical fitness, relaxation or stress
management, mental acuity, self-esteem, including personal appearance, sleep
management, or sexual function?
Yes à Go to b.
No à Not general wellness, outside the scope of this guidance.
b. Does the product’s intended use include a claim relating to a disease or
medical condition?
Yes à Go to c.
No à Go to 2.
c. Is the disease or medical condition a chronic one for which it is well
understood that healthy lifestyle choices may play a part in helping to reduce
its risk or impact, as discussed in this guidance?
Yes à Go to d.
No à Not general wellness, outside the scope of this guidance.
d. Does the claim use language that the product may help to reduce the risk of, or
may help living well with, a chronic disease or condition, as discussed in this
guidance?
Yes à Go to 2.
No à Not general wellness, outside the scope of this guidance.
Does the product present inherent risks to a user’s safety (i.e., is the device low
risk)?
Is the product invasive, involve an intervention or technology that would pose a risk
to the user’s safety if device controls are not applied, such as risks from lasers,
radiation exposure, implantation procedures, raise novel questions of usability, or
raise questions of biocompatibility? In answering this question, consider whether
CDRH actively regulates products of the same type as the product in question.
Yes à Not general wellness, outside the scope of this guidance.
No à General wellness product.

Contenu connexe

Tendances

IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAMANIKANDAN V
 
Fast track drugs - Rapid study and Approval
Fast track drugs - Rapid study and ApprovalFast track drugs - Rapid study and Approval
Fast track drugs - Rapid study and ApprovalDebashish Sarkar
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillanceGaurav Sharma
 
CFTCC Workshop: IND Exemption, Preparation, and Maintenance
CFTCC Workshop: IND Exemption, Preparation, and MaintenanceCFTCC Workshop: IND Exemption, Preparation, and Maintenance
CFTCC Workshop: IND Exemption, Preparation, and MaintenanceCFTCC
 
W hite Paper On Medical Devices
W hite Paper On Medical DevicesW hite Paper On Medical Devices
W hite Paper On Medical DevicesAllisonBooth
 
Clinical research management slide
Clinical research management slideClinical research management slide
Clinical research management slideakashgayakwad1
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Jacobe2008
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANDeveshDRA
 
FDA-Fast Track Designation
FDA-Fast Track DesignationFDA-Fast Track Designation
FDA-Fast Track DesignationVansh Raina
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentJonathan Servoss
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsMichael Swit
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicinesTGA Australia
 
Regulatory Highlights and Drug Development in China
Regulatory Highlights and Drug Development in ChinaRegulatory Highlights and Drug Development in China
Regulatory Highlights and Drug Development in ChinaMedpace
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agenciesUrmila Aswar
 
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...Arooj Abid
 
Pharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reportingPharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reportingSMS MEDICAL COLLEGE
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - IntroductionDr. Jigar Vyas
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overviewAcri India
 

Tendances (20)

IND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDAIND, NDA, ANDA, SNDA
IND, NDA, ANDA, SNDA
 
Fast track drugs - Rapid study and Approval
Fast track drugs - Rapid study and ApprovalFast track drugs - Rapid study and Approval
Fast track drugs - Rapid study and Approval
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 
CFTCC Workshop: IND Exemption, Preparation, and Maintenance
CFTCC Workshop: IND Exemption, Preparation, and MaintenanceCFTCC Workshop: IND Exemption, Preparation, and Maintenance
CFTCC Workshop: IND Exemption, Preparation, and Maintenance
 
W hite Paper On Medical Devices
W hite Paper On Medical DevicesW hite Paper On Medical Devices
W hite Paper On Medical Devices
 
Clinical research management slide
Clinical research management slideClinical research management slide
Clinical research management slide
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
 
FDA-Fast Track Designation
FDA-Fast Track DesignationFDA-Fast Track Designation
FDA-Fast Track Designation
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicines
 
Regulatory Highlights and Drug Development in China
Regulatory Highlights and Drug Development in ChinaRegulatory Highlights and Drug Development in China
Regulatory Highlights and Drug Development in China
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...
Definitions according to Drug Regulatory Authority of Pakistan (DRAP medical ...
 
Dcgi adverse event
Dcgi adverse eventDcgi adverse event
Dcgi adverse event
 
Pharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reportingPharmacovigilance and Method of ADR reporting
Pharmacovigilance and Method of ADR reporting
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
 
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand PirouziICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overview
 

En vedette

11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_santeMarket iT
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
 
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Market iT
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Market iT
 
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...Market iT
 
Public Notification of Emerging Postmarket Medical Device Signals
Public Notification of Emerging  Postmarket Medical Device SignalsPublic Notification of Emerging  Postmarket Medical Device Signals
Public Notification of Emerging Postmarket Medical Device SignalsMarket iT
 
Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Market iT
 
Strategie e sante-2020
Strategie e sante-2020Strategie e sante-2020
Strategie e sante-2020Market iT
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceMarket iT
 
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Market iT
 
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...Market iT
 
Programme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILProgramme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILMarket iT
 
Rapport codeem 2015
Rapport codeem 2015Rapport codeem 2015
Rapport codeem 2015Market iT
 
Sia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoSia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoMarket iT
 
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCLe FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCMarket iT
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Market iT
 
Iffres 31 03-2016 présentation matinale santé Market iT
Iffres 31 03-2016  présentation matinale santé Market iTIffres 31 03-2016  présentation matinale santé Market iT
Iffres 31 03-2016 présentation matinale santé Market iTMarket iT
 
NHS England - Managing conflicts of interest
NHS England - Managing conflicts of interestNHS England - Managing conflicts of interest
NHS England - Managing conflicts of interestMarket iT
 
Journée nationale innovation santé
Journée nationale innovation santéJournée nationale innovation santé
Journée nationale innovation santéMarket iT
 
Loi santé et Transparence
Loi santé et TransparenceLoi santé et Transparence
Loi santé et TransparenceMarket iT
 

En vedette (20)

11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
 
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
 
Public Notification of Emerging Postmarket Medical Device Signals
Public Notification of Emerging  Postmarket Medical Device SignalsPublic Notification of Emerging  Postmarket Medical Device Signals
Public Notification of Emerging Postmarket Medical Device Signals
 
Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015
 
Strategie e sante-2020
Strategie e sante-2020Strategie e sante-2020
Strategie e sante-2020
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & Transparence
 
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
Jeudi 31 mars 2016 | Site Internet et webmarketing : Analyse des points-clé a...
 
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...Jeudi 24 mars 2016 | Etudes non interventionnelles :  respecter les contraint...
Jeudi 24 mars 2016 | Etudes non interventionnelles : respecter les contraint...
 
Programme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CILProgramme 10ème universite afcdp des CIL
Programme 10ème universite afcdp des CIL
 
Rapport codeem 2015
Rapport codeem 2015Rapport codeem 2015
Rapport codeem 2015
 
Sia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoSia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_info
 
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PCLe FBI autorisé par la Cour Suprême à pirater n'importe quel PC
Le FBI autorisé par la Cour Suprême à pirater n'importe quel PC
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015
 
Iffres 31 03-2016 présentation matinale santé Market iT
Iffres 31 03-2016  présentation matinale santé Market iTIffres 31 03-2016  présentation matinale santé Market iT
Iffres 31 03-2016 présentation matinale santé Market iT
 
NHS England - Managing conflicts of interest
NHS England - Managing conflicts of interestNHS England - Managing conflicts of interest
NHS England - Managing conflicts of interest
 
Journée nationale innovation santé
Journée nationale innovation santéJournée nationale innovation santé
Journée nationale innovation santé
 
Loi santé et Transparence
Loi santé et TransparenceLoi santé et Transparence
Loi santé et Transparence
 

Similaire à FDA - General Wellness: Policy for Low Risk Devices

Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...
Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...
Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...CRF Health
 
Fda mobile medical apps 2013
Fda mobile medical apps 2013Fda mobile medical apps 2013
Fda mobile medical apps 2013Alfonso Gadea
 
Final FDA guidance on Medical Devices and Risk Analysis
Final FDA guidance on Medical Devices and Risk AnalysisFinal FDA guidance on Medical Devices and Risk Analysis
Final FDA guidance on Medical Devices and Risk AnalysisDavid Sweigert
 
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...NextWorks
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to MobileDale Cooke
 
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...Path of the Blue Eye Project
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsMichael Swit
 
WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019Niraj Bartaula
 
World Health Organization Model List of Essential Medicines 21st List 2019
World Health Organization Model List of Essential Medicines 21st List 2019World Health Organization Model List of Essential Medicines 21st List 2019
World Health Organization Model List of Essential Medicines 21st List 2019Nabin Bist
 
Overview of FDA Regulation of Medical Devices
Overview of FDA Regulation of Medical DevicesOverview of FDA Regulation of Medical Devices
Overview of FDA Regulation of Medical DevicesMichael Swit
 
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...NextWorks
 
FDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyFDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyDr Dev Kambhampati
 
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...NextWorks
 
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...Dr Dev Kambhampati
 
Gui final referencing_approved _oct 2020
Gui final referencing_approved _oct 2020Gui final referencing_approved _oct 2020
Gui final referencing_approved _oct 2020Ajay B. Kumar
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESArunpandiyan59
 

Similaire à FDA - General Wellness: Policy for Low Risk Devices (20)

mobile medical applications
mobile medical applicationsmobile medical applications
mobile medical applications
 
Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...
Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...
Guidance for Industry and Food and Drug Administration Staff: Mobile Medical ...
 
Fda mobile medical apps 2013
Fda mobile medical apps 2013Fda mobile medical apps 2013
Fda mobile medical apps 2013
 
Final FDA guidance on Medical Devices and Risk Analysis
Final FDA guidance on Medical Devices and Risk AnalysisFinal FDA guidance on Medical Devices and Risk Analysis
Final FDA guidance on Medical Devices and Risk Analysis
 
Nz categorisationof products
Nz categorisationof productsNz categorisationof products
Nz categorisationof products
 
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
HIGHLIGHTED: Dissemination of Patient-Specific Information from Devices by De...
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to Mobile
 
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
FDA Draft Guidance on Responding to Unsolicited Requests for Off-Label Drug I...
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019WHO model list of essential medicines: 21st list 2019
WHO model list of essential medicines: 21st list 2019
 
World Health Organization Model List of Essential Medicines 21st List 2019
World Health Organization Model List of Essential Medicines 21st List 2019World Health Organization Model List of Essential Medicines 21st List 2019
World Health Organization Model List of Essential Medicines 21st List 2019
 
Overview of FDA Regulation of Medical Devices
Overview of FDA Regulation of Medical DevicesOverview of FDA Regulation of Medical Devices
Overview of FDA Regulation of Medical Devices
 
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...
HIGHLIGHTED: Guidance for Industry: Fulfilling Regulatory Requirements for Po...
 
medical-device-forum.pptx
medical-device-forum.pptxmedical-device-forum.pptx
medical-device-forum.pptx
 
FDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & SafetyFDA Drug Approval Regulations & Safety
FDA Drug Approval Regulations & Safety
 
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...
HIGHLIGHTED: Guidance for Industry: Internet/Social Media Platforms: Correcti...
 
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...
Dr Dev Kambhampati | Considering Whether an FDA-Regulated Product Involves th...
 
Gui final referencing_approved _oct 2020
Gui final referencing_approved _oct 2020Gui final referencing_approved _oct 2020
Gui final referencing_approved _oct 2020
 
Restricted list final_2010
Restricted list final_2010Restricted list final_2010
Restricted list final_2010
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 

Plus de Market iT

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...Market iT
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Market iT
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Market iT
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin IIMarket iT
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerteMarket iT
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationMarket iT
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017Market iT
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteMarket iT
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineMarket iT
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPRMarket iT
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMarket iT
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalMarket iT
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthiqueMarket iT
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)Market iT
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Market iT
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Market iT
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxMarket iT
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016Market iT
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Market iT
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Market iT
 

Plus de Market iT (20)

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin II
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerte
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislation
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerte
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_line
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPR
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practice
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médical
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicaux
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016
 

Dernier

Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableGENUINE ESCORT AGENCY
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...GENUINE ESCORT AGENCY
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...parulsinha
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426jennyeacort
 
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service AvailableGENUINE ESCORT AGENCY
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...mahaiklolahd
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...narwatsonia7
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...tanya dube
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...khalifaescort01
 
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...parulsinha
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Dipal Arora
 
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...narwatsonia7
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...narwatsonia7
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableDipal Arora
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...chetankumar9855
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableGENUINE ESCORT AGENCY
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...hotbabesbook
 

Dernier (20)

Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
 
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
 
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
 
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 

FDA - General Wellness: Policy for Low Risk Devices

  • 1. General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: January 20, 2015. You should submit comments and suggestions regarding this draft document within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to http://www.regulations.gov. Identify all comments with the docket number listed in the notice of availability that publishes in the Federal Register. For questions regarding this document, contact the Office of the Center Director at 301-796- 5900. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health
  • 2. Preface Additional Copies Additional copies are available from the Internet. You may also send an e-mail request to dsmica@fda.hhs.gov to receive an electronic copy of the guidance or send a fax request to 301- 847-8149 to receive a hard copy. Please use the document number 1300013 to identify the guidance you are requesting.
  • 3. Table of Contents I. INTRODUCTION .......................................................................................................................................1 II. POLICY ON LOW RISK GENERAL WELLNESS PRODUCTS .........................................................2 III. GENERAL WELLNESS PRODUCTS......................................................................................................3 IV. LOW RISK...................................................................................................................................................5 V. EXAMPLES OF LOW RISK GENERAL WELLNESS PRODUCTS ...................................................6 DECISION ALGORITHM FOR GENERAL WELLNESS PRODUCTS ......................................................8
  • 4. Contains Nonbinding Recommendations Draft - Not for Implementation 1 General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance. I. Introduction The Food and Drug Administration (FDA) is issuing this guidance document to provide clarity to industry and FDA staff on the Center for Devices and Radiological Health’s (CDRH’s) compliance policy for low risk products that promote a healthy lifestyle (general wellness products)1 . This guidance does not apply to products (e.g., drugs, biologics, dietary supplements, foods, or cosmetics) regulated by other FDA Centers or to combination products,2 including those regulated by CDRH. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory 1 This guidance does not change or rescind any requirements of the FD&C Act or any applicable regulations. This guidance also does not preclude FDA from consulting with the Consumer Product Safety Commission (CPSC) as to whether a general wellness product is a consumer product under CPSC’s authority or a device. FDA may coordinate with other agencies and authorities, such as the CPSC, to determine jurisdiction over products. If a product is a device under section 201(h) of the FD&C Act, it is generally excluded from CPSC’s authority over “consumer products” under the Consumer Product Safety Act (15 U.S.C. § 2052(a)(5)(ii)(H)). However, CPSC and FDA may both have jurisdiction over certain medical devices under other statutory authorities the CPSC administers. 2 For determinations on whether a combination product meets the statutory definition of a medical device, contact the Office of Combination Products at combination@fda.gov.
  • 5. Contains Nonbinding Recommendations Draft - Not for Implementation 2 requirements are cited. The use of the word should in Agency guidance means that something is suggested or recommended, but not required. II. Policy on Low Risk General Wellness Products CDRH does not intend to examine low risk general wellness products to determine whether they are devices3 within the meaning of the FD&C Act or, if they are devices, whether they comply with the premarket review and post-market regulatory requirements for devices under the FD&C Act and implementing regulations, including, but not limited to: registration and listing and premarket notification requirements (21 CFR Part 807); labeling requirements (21 CFR Part 801 and 21 CFR 809.10); good manufacturing practice requirements as set forth in the Quality System regulation (21 CFR Part 820); and Medical Device Reporting (MDR) requirements (21 CFR Part 803). For purposes of this guidance, CDRH defines general wellness products as products that (1) are intended for only general wellness use, as defined in this guidance, and (2) present a very low risk to users’ safety. General wellness products may include exercise equipment, audio recordings, video games, software programs4 and other products that are commonly, though not exclusively, available from retail establishments (including online retailers and distributors that offer software to be directly downloaded), provided these two criteria are met. CDRH regularly receives inquiries about whether particular products are devices as defined by the FD&C Act. There are instances where certain general wellness products, as discussed in this guidance, do not meet the definition of a device under section 201(h) of the FD&C Act and therefore are not subject to the FD&C Act’s regulatory requirements for devices. We have included examples of these kinds of products to illustrate the scope of this guidance, rather than to suggest they meet the device definition. A product's inclusion under this guidance does not establish that it has been shown to be safe, effective, and not misbranded for its intended use. 3 The term “device” is defined in 201(h) of the FD&C Act to include an “instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is …intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man … or intended to affect the structure or any function of the body of man...” 4 For more discussion regarding FDA’s regulatory approach towards certain mobile medical applications, see the FDA Guidance: Mobile Medical Applications, issued on September 25, 2013, available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM2633 66.pdf.
  • 6. Contains Nonbinding Recommendations Draft - Not for Implementation 3 III. General Wellness Products A general wellness product, for the purposes of this guidance, has (1) an intended use that relates to a maintaining or encouraging a general state of health or a healthy activity, or (2) an intended use claim that associates the role of healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or conditions and where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition). If the product’s intended uses are not limited to the above general wellness intended uses, this guidance does not apply. The first category of general wellness intended uses involve claims about sustaining or offering general improvement to conditions and functions associated with a general state of health that do not make any reference to diseases or conditions. For the purposes of this guidance, this first category of general wellness claims relate to: · weight management, · physical fitness, including products intended for recreational use, · relaxation or stress management, · mental acuity, · self-esteem (e.g., devices with a cosmetic function that make claims related only to self-esteem), · sleep management, or · sexual function. The following are examples of this category of general wellness claims: · Claims to promote or maintain a healthy weight, encourage healthy eating, or assist with weight loss goals; · Claims to promote relaxation or manage stress when there is no reference to anxiety disorders or other reference to a disease or condition; · Claims to increase, improve, or enhance the flow of qi; · Claims to improve mental acuity, instruction following, concentration, problem- solving, multitasking, resource management, decision-making, logic, pattern recognition or eye-hand coordination; · Claims to promote physical fitness, such as to help log, track, or trend exercise activity, measure aerobic fitness, improve physical fitness, develop or improve endurance, strength or coordination, or improve energy; · Claims to promote sleep management, such as to track sleep trends; · Claims to promote self-esteem, such as to boost self-esteem;
  • 7. Contains Nonbinding Recommendations Draft - Not for Implementation 4 · Claims that address a specific body structure or function, such as to increase or improve muscle size or body tone, tone or firm the body or muscle, enhance cardiac function, or enhance or improve sexual performance; · Claims to improve general mobility or to assist individuals who are mobility impaired or who have limited mobility in a recreational activity; and · Claims to enhance an individual’s participation in recreational activities by monitoring the consequences of participating in such activities, such as to monitor heart rate or monitor frequency or impact of collisions. The following are examples of claims that do not fall into this category of general wellness claims: · A claim that a product will treat or diagnose obesity; · A claim that a product will treat an eating disorder, such as anorexia; · A claim that a product helps treat anxiety; · A claim that a computer game will diagnose or treat autism; · A claim that a product will treat muscle atrophy or erectile dysfunction; · A claim to restore a structure or function impaired due to a disease, e.g., a claim that a prosthetic device enables amputees to play basketball.5 The second category of general wellness intended uses is comprised of two subcategories: 1) intended uses to promote, track, and/or encourage choice(s), which, as part of a healthy lifestyle, may help to reduce the risk of certain chronic diseases or conditions; and 2) intended uses to promote, track, and/or encourage choice(s) which, as part of a healthy lifestyle, may help living well with certain chronic diseases or conditions. Both subcategories of disease-related general wellness claims should only contain references where it is well understood that healthy lifestyle choices may reduce the risk or impact of a chronic disease or medical condition. That is, the claim that the healthy lifestyle choice(s) may play an important role in health outcomes should be generally accepted; such associations are typically described in peer-reviewed scientific publications. Examples of chronic diseases for which a healthy lifestyle is associated with risk reduction or help in living well with that disease include heart disease, high blood pressure, and type 2 diabetes. The following are examples of this category of disease-related general wellness claims: 5 Devices intended to restore a structure or function impaired due to a disease may be regulated by FDA as individually classified recreational use devices or products classified in a general classification. For example, an artificial limb prosthesis intended to provide disabled persons the ability to run may be regulated under 21 CFR 890.3420 or 21 CFR 890.3500.
  • 8. Contains Nonbinding Recommendations Draft - Not for Implementation 5 · Product X promotes physical activity, which, as part of a healthy lifestyle, may help reduce the risk of high blood pressure. · Software Product Y tracks your caloric intake and helps you manage a healthy eating plan to maintain a healthy weight and balanced diet. Healthy weight and balanced diet may help living well with high blood pressure and type 2 diabetes. · Product Z tracks activity sleep patterns and promotes healthy sleep habits, which, as part of a healthy lifestyle, may help reduce the risk for developing type 2 diabetes. IV. Low Risk CDRH’s general wellness policy does not extend to devices that present inherent risks to a user’s safety. Whether a device is low risk for purposes of this guidance is determined by whether or not the product: 1) is invasive6 ; 2) involves an intervention or technology that may pose a risk to a user’s safety if device controls are not applied, such as risks from lasers, radiation exposure, or implants; 3) raises novel questions of usability; or 4) raises questions of biocompatibility. If the answer to any of these questions is yes, the device is not a low risk general wellness product and is not covered by this guidance. The following are examples of products that present inherent risks to a user’s safety and would not be considered “low risk” as described in this guidance: · Sunlamp products promoted for tanning purposes, due to risks to a user’s safety from the ultraviolet radiation, including, without limitation, an increased risk of skin cancer. · Implants promoted for improved self-image or enhanced sexual function, due to risks to users such as rupture or adverse reaction to implant materials, and risks associated with the implantation procedure. · A laser product that claims to improve confidence in user’s appearance by rejuvenating the skin. Although the claims of rejuvenating the skin and improving confidence in user’s appearance are general wellness claims, laser technology presents risks of skin and eye burns and presents usability considerations that may be addressed with labeling and other device controls. 6 For purposes of this guidance, “invasive” means penetrates or pierces the skin or mucous membranes of the body.
  • 9. Contains Nonbinding Recommendations Draft - Not for Implementation 6 In assessing whether a device is low risk for purposes of this guidance, FDA recommends that you also consider whether CDRH actively regulates products of the same type as the product in question. For example, CDRH currently regulates external penile rigidity devices, which are devices intended to create or maintain sufficient penile rigidity for sexual intercourse, under 21 CFR 876.5020 as class II devices exempt from premarket notification with special controls. The special controls for these devices address risks to health that are associated with the use of these devices, including, without limitation, tissue injury, trauma or infection.7 Therefore, these types of devices would not be considered low risk general wellness products. V. Examples of Low Risk General Wellness Products Illustrative Example 1: A mobile application plays music to “soothe and relax” an individual and to “manage stress.” These claims relate only to relaxation or stress management, not to any disease or medical condition, and thus are general wellness claims. In addition, the technology to play music does not present inherent risks to a user’s safety. Therefore, this product meets both criteria for a low risk general wellness product. Illustrative Example 2: A mobile application that solely monitors and records daily energy expenditure and cardiovascular workout activities to “allow awareness of one’s exercise activities to improve or maintain good cardiovascular health.” This claim relates to a specific organ only in the context of general health and does not refer to a disease or medical condition. In addition, to the extent the monitoring or recording exercise activities present risks (such as inaccuracy), when made in the absence of disease or medical condition claims, the risks to the user’s safety are low. Therefore, this product meets both criteria for a low risk general wellness product. Illustrative Example 3: A mobile application monitors and records food consumption to “manage dietary activity for weight management and alert the user, healthcare provider, or family member of unhealthy dietary activity”. This claim relates to dietary choices and weight management, and thus is a general wellness claim. In addition, the technology for monitoring or recording food consumption poses a low risk to the user’s safety. Therefore, this product meets both criteria for a low risk general wellness product. 7 See the FDA Guidance: Class II Special Controls Guidance Document: External Penile Rigidity Devices, issued on December 28, 2004, available at http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm072098.htm.
  • 10. Contains Nonbinding Recommendations Draft - Not for Implementation 7 Illustrative Example 4: A portable product that claims to monitor the pulse rate of users during exercise and hiking. This claim relates only to exercise and hiking and does not refer to a disease or medical condition. Thus, it is a general wellness claim. In addition, the technology for monitoring poses a low risk to the user’s safety. Therefore, this product meets both criteria for a low risk general wellness product. Illustrative Example 5: A product is intended to mechanically exfoliate the face, hands and feet to make the skin smoother and softer. This claim relates to self-esteem and does not refer to a specific disease or medical condition, and thus is a general wellness claim. In addition, the technology for exfoliating the face poses a low risk to the user’s safety as it does not penetrate the stratum corneum. Therefore, this product meets both criteria for a low risk general wellness product. Note: However, if the product exfoliates the skin to enhance the delivery of a topically applied product containing one or more active pharmaceutical ingredients through the stratum corneum, the product would present inherent risks to the user’s safety because of its invasive nature. Therefore, then, the product would not be a low risk general wellness product.
  • 11. Contains Nonbinding Recommendations Draft - Not for Implementation 8 Decision Algorithm for General Wellness Products 1. Does the product make only general wellness claims? a. Does the product’s intended use and claims refer to sustaining or offering general improvement to conditions and functions associated with a general state of health: weight management, physical fitness, relaxation or stress management, mental acuity, self-esteem, including personal appearance, sleep management, or sexual function? Yes à Go to b. No à Not general wellness, outside the scope of this guidance. b. Does the product’s intended use include a claim relating to a disease or medical condition? Yes à Go to c. No à Go to 2. c. Is the disease or medical condition a chronic one for which it is well understood that healthy lifestyle choices may play a part in helping to reduce its risk or impact, as discussed in this guidance? Yes à Go to d. No à Not general wellness, outside the scope of this guidance. d. Does the claim use language that the product may help to reduce the risk of, or may help living well with, a chronic disease or condition, as discussed in this guidance? Yes à Go to 2. No à Not general wellness, outside the scope of this guidance. Does the product present inherent risks to a user’s safety (i.e., is the device low risk)? Is the product invasive, involve an intervention or technology that would pose a risk to the user’s safety if device controls are not applied, such as risks from lasers, radiation exposure, implantation procedures, raise novel questions of usability, or raise questions of biocompatibility? In answering this question, consider whether CDRH actively regulates products of the same type as the product in question. Yes à Not general wellness, outside the scope of this guidance. No à General wellness product.